Get the Stockscreener App
1.24
2.48%
0.03
Vivani Medical Inc stock is traded at $1.24, with a volume of 29,216.
It is up +2.48% in the last 24 hours and down -20.51% over the past month.
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
See More
Previous Close:
$1.21
Open:
$1.21
24h Volume:
29,216
Relative Volume:
0.22
Market Cap:
$73.46M
Revenue:
-
Net Income/Loss:
$-25.65M
P/E Ratio:
-2.5306
EPS:
-0.49
Net Cash Flow:
$-24.59M
1W Performance:
-0.80%
1M Performance:
-20.51%
6M Performance:
+7.83%
1Y Performance:
-8.15%
1-Day Range:
$1.2001
$1.2516
1-Week Range:
$1.18
$1.26
52-Week Range:
$0.9054
$1.80
Vivani Medical Inc Stock (VANI) Company Profile
Name
Vivani Medical Inc
Sector
Industry
Phone
818-833-5000
Address
1350 S. LOOP ROAD, ALAMEDA
Compare VANI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VANI
Vivani Medical Inc
|
1.24 | 73.46M | 0 | -25.65M | -24.59M | -0.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Vivani Medical Inc Stock (VANI) Latest News
How to read the order book for Vivani Medical Inc.Buy Signal & Free Community Supported Trade Ideas - Newser
Measuring Vivani Medical Inc.’s beta against major indices2025 Year in Review & Weekly Watchlist for Consistent Profits - Newser
Is it too late to sell Vivani Medical Inc.Treasury Yields & Weekly Hot Stock Watchlists - Newser
Vivani Medical Inc. Sees Relief Buying After Extended Drop2025 Earnings Surprises & Community Consensus Stock Picks - thegnnews.com
Vivani Medical CEO Adam Mendelsohn to Present at the H.C. - GlobeNewswire
Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025 - au.finance.yahoo.com
Combining machine learning predictions for Vivani Medical Inc.July 2025 Drop Watch & Reliable Price Breakout Alerts - Newser
Is Vivani Medical Inc. still worth holding after the dipMarket Trend Review & Smart Swing Trading Alerts - Newser
What data driven models say about Vivani Medical Inc.’s futureJuly 2025 PostEarnings & Technical Confirmation Alerts - Newser
Tools to assess Vivani Medical Inc.’s risk profile2025 Performance Recap & Reliable Volume Spike Trade Alerts - Newser
What technical models suggest about Vivani Medical Inc.’s comeback2025 Volume Leaders & Low Risk High Win Rate Stock Picks - Newser
Trend analysis for Vivani Medical Inc. this weekWeekly Risk Summary & Community Verified Trade Signals - Newser
Does Vivani Medical Inc. fit your quant trading modelJuly 2025 Opening Moves & Expert Curated Trade Setups - Newser
What earnings revisions data tells us about Vivani Medical Inc.Weekly Gains Report & Precise Swing Trade Alerts - Newser
How high can Vivani Medical Inc. stock price go in 2025July 2025 Opening Moves & Low Risk Entry Point Guides - Newser
Relative strength of Vivani Medical Inc. in sector analysisJobs Report & Precise Swing Trade Alerts - Newser
Volume spikes in Vivani Medical Inc. stock – what they meanJuly 2025 Recap & Expert Approved Momentum Ideas - Newser
Sector ETF performance correlation with Vivani Medical Inc.Buy Signal & Safe Capital Preservation Plans - Newser
What Fibonacci levels say about Vivani Medical Inc. reboundJuly 2025 Patterns & Community Supported Trade Ideas - Newser
Why Vivani Medical Inc. stock attracts strong analyst attentionJuly 2025 Analyst Calls & Growth Focused Investment Plans - Newser
Order flow analysis tools used on Vivani Medical Inc.July 2025 Market Mood & Low Risk Investment Opportunities - Newser
Is Vivani Medical Inc. stock entering bullish territoryJuly 2025 Summary & Expert Approved Trade Ideas - Newser
When is the best time to exit Vivani Medical Inc.Market Sentiment Review & Comprehensive Market Scan Reports - Newser
Vivani Medical (NASDAQ:VANI) Issues Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
Vivani Medical (NASDAQ:VANI) Trading Down 0.8% Following Weak Earnings - MarketBeat
Using data filters to optimize entry into Vivani Medical Inc.Bear Alert & Low Risk High Win Rate Stock Picks - Newser
What indicators show strength in Vivani Medical Inc.Earnings Growth Summary & Real-Time Chart Breakout Alerts - Newser
Predicting Vivani Medical Inc. trend using moving averages2025 EndofYear Setup & Daily Risk Controlled Trade Plans - Newser
RSI and MACD Indicate Shift in Vivani Medical Inc. SentimentJuly 2025 Volume & Safe Entry Momentum Stock Tips - classian.co.kr
Vivani Medical Inc.’s volatility index tracking explainedJuly 2025 EndofMonth & Low Risk Entry Point Tips - Newser
How sensitive is Vivani Medical Inc. to inflationEarnings Recap Report & Long-Term Growth Stock Strategies - thegnnews.com
What makes Vivani Medical Inc. stock price move sharply2025 Volume Leaders & Expert Curated Trade Ideas - Newser
Analyzing recovery setups for Vivani Medical Inc. investorsInsider Selling & Accurate Buy Signal Alerts - Newser
Using flow based indicators on Vivani Medical Inc.Quarterly Trade Summary & Daily Technical Stock Forecast Reports - Newser
Vivani Medical Inc Stock (VANI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Vivani Medical Inc Stock (VANI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Williams Gregg | Director |
May 14 '25 |
Buy |
1.01 |
3,499 |
3,534 |
13,831,654 |
| Williams Gregg | Director |
May 16 '25 |
Buy |
1.01 |
2,405 |
2,429 |
13,840,895 |
| Williams Gregg | Director |
Apr 24 '25 |
Buy |
1.01 |
1,113 |
1,124 |
13,828,155 |
| Williams Gregg | Director |
Apr 21 '25 |
Buy |
1.01 |
1,569 |
1,585 |
13,826,799 |
| Williams Gregg | Director |
Apr 22 '25 |
Buy |
1.01 |
243 |
245 |
13,827,042 |
| Williams Gregg | Director |
Apr 09 '25 |
Buy |
1.02 |
18,529 |
18,900 |
13,822,919 |
| Williams Gregg | Director |
Apr 11 '25 |
Buy |
1.01 |
2,311 |
2,334 |
13,825,230 |
| Williams Gregg | Director |
Apr 08 '25 |
Buy |
1.02 |
62,899 |
64,157 |
13,804,390 |
| Williams Gregg | Director |
Apr 07 '25 |
Buy |
0.99 |
58,583 |
57,997 |
13,741,491 |
| Williams Gregg | Director |
Apr 07 '25 |
Buy |
0.99 |
44,400 |
43,956 |
4,799,200 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):